Biomedical Occupation or Discipline – Page 6

U.S. Congressional Report Calls for $15 Billion to Bolster Biotech Leadership Amid Rising Chinese Competition

3 months ago talkbio0Tagged Bioeconomy, Biomanufacturing Strategy, Biotech Competition, Biotechnology, Biotechnology Advantage, China, Investments, National Security Commission, Tech Rivalry, U.S.-China, United States

U.S. Biotechnology Advantage, China Biotech Competition, National Security Commission on Emerging Biotechnology, Biotechnology Investment, Biomanufacturing Strategy, U.S.-China Tech Rivalry, Bioeconomy

Rocket Pharmaceuticals Expands Leadership with J&J and AstraZeneca Alumni to Strengthen Gene Therapy Commercialization

3 months ago talkbio0Tagged AstraZeneca, Biotechnology, Chaudhuri, commercial, gene therapy, Kresladi, launch, Market, Mozafancogene Autotemcel, Rocket, Sarbani

Rocket Pharmaceuticals, gene therapy, commercial leadership, Sarbani Chaudhuri, Johnson & Johnson, AstraZeneca, commercial launch, gene therapy market, rare diseases, biotechnology, Kresladi, RP-L102.

Exclusive: Merida Biosciences gets $121M to treat autoimmune and allergy diseases at their roots

3 months ago talkbio0Tagged Autoimmune, Autoimmune Diseases, Precision - temporal

Autoimmune, Autoimmune Diseases, Precision – temporal

GSKs newest neuro pact is with ABL Bio, a Sanofi-partnered South Korean biotech

3 months ago talkbio0Tagged Abetalipoproteinemia, Bio, Blood - brain barrier anatomy, Grabody-B, IGF1R gene, Neurodegenerative Disorders, SmithKline Beecham

Abetalipoproteinemia, SmithKline Beecham, Bio, Grabody-B, Neurodegenerative Disorders, Blood – brain barrier anatomy, IGF1R gene

Mass Firings at FDA Spark Concerns Over Agency’s Future

3 months ago talkbio0Tagged Administration occupational activities, Changing, Drug Regulations, Leadership, public health medicine (field), Transplant Registry Unified Management Program, United States Food and Drug Administration

FDA, layoffs, leadership changes, public health, drug regulation, Trump administration

Beyond Black Box: How Data-Driven AI Is Transforming RNA Medicine Development

3 months ago talkbio0Tagged Aortic Valve Insufficiency, black box, Clinical Trials, Data-Driven AI, datasets, development aspects, Drug Design, RNA medicine, Transforming RNA Medicine Development

Aortic Valve Insufficiency, development aspects, RNA medicine, black box, Data-Driven AI, Transforming RNA Medicine Development, datasets, Drug Design, Clinical Trials